| 000 | 01189nam a22003011a 4500 | ||
|---|---|---|---|
| 001 | vtls000251222 | ||
| 003 | UG-KaMUL | ||
| 005 | 20250616035911.0 | ||
| 020 | _a 9283212665 | ||
| 039 |
_y 200805141200 _z 910 |
||
| 040 | _aUG-KaMUL | ||
| 060 |
_a QV 77.9 _b In8s 1996 |
||
| 110 | _a IARC Working Group on the Evaluation of Carcinogenic Risks to Humans . | ||
| 245 |
_aSome pharmaceutical drugs / _c IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (1996 : Lyon, France) _b |
||
| 260 |
_aLyon : _bInternational Agency for Research Cancer ; World Health Or ganization, _c1996. |
||
| 300 |
_a 514 p. : _b ill. ; _c 24 cm. |
||
| 440 |
_a IARC monographs on the evaluation of carcinogenic risks to humans ; _v v. 66 |
||
| 504 | _a Includes bibliographical references and index. | ||
| 650 |
_aBenzodiazepines _xtoxicity _v _y _z |
||
| 650 |
_aEstrogen Antagonists _xtoxicity _v _y _z |
||
| 650 |
_aAntillipemic Agents _xtoxicity _v _y _z |
||
| 650 |
_aNeoplasms _xchemically induced _v _y _z |
||
| 710 | _a International Agency for Research Cancer | ||
| 710 | _a World Health Organization | ||
| 942 |
_2ddc _BK _cBK |
||
| 999 |
_c414958 _d414958 |
||